Maertens and colleagues found that combined suppression of BRAF/MEK together with entinostat resulted in additional downregulation of NHEJ related genes, including XRCC4, XRCC5, XRCC6, PNKP and PARP3, and reduced melanoma cell survival. Here, BRAF is linked to melanoma.